Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.25
Delayed Data
As of 4:00pm ET
 +0.02 / +0.22%
Today’s Change
5.49
Today|||52-Week Range
9.60
+17.53%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close9.23
Today’s open9.20
Day’s range9.02 - 9.41
Volume507,995
Average volume (3 months)302,576
Market cap$724.7M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+137.04%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.34

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...+0.30+1.52%
NTRANatera Inc+0.11+0.96%
GHDXGenomic Health Inc+0.39+1.27%
KANGiKang Healthcare Gro...+0.01+0.06%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs